Molecular genetics of familial parkinsonism

被引:10
作者
Wszolek, ZK
Markopoulou, K
机构
[1] Mayo Clin Jacksonville, Dept Neurol, Jacksonville, FL 32224 USA
[2] Univ Nebraska, Med Ctr, Dept Internal Med, Neurol Sect, Omaha, NE 68198 USA
关键词
Parkinson's disease; idiopathic parkinsonism; parkinsonism-plus syndromes;
D O I
10.1016/S1353-8020(99)00030-9
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Parkinson's disease (PD) is a progressive, neurodegenerative disorder associated with tremor, rigidity, bradykinesia, and postural instability. There exists a familial form of PD that is indistinguishable from the sporadic form. In addition, there exists a class of syndromes classified as parkinsonism-plus syndromes (PPS), in which parkinsonism is an essential but not the only phenotypic characteristic. The etiology of PD remains unclear. Both environmental and genetic factors contribute to the disease pathogenesis. Recent progress in the molecular genetics of parkinsonism has demonstrated that six different chromosomal regions are associated with forms of familial parkinsonism. Mutations in four candidate genes have been identified and include both point mutations and deletions. Both gain-of-function and loss-of-function mutational mechanisms have been implicated. The molecular genetic characterization has led to a new classification of PD and PPS based on the type of genetic defect. Understanding the mechanisms by which these mutations lead to disease should provide further insights into the etiology of parkinsonism. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:145 / 155
页数:11
相关论文
共 98 条
[1]   STRUCTURE AND NOVEL EXONS OF THE HUMAN-TAU GENE [J].
ANDREADIS, A ;
BROWN, WM ;
KOSIK, KS .
BIOCHEMISTRY, 1992, 31 (43) :10626-10633
[2]   Glutathione transferases catalyse the detoxication of oxidized metabolites (o-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes [J].
Baez, S ;
SeguraAguilar, J ;
Widersten, M ;
Johansson, AS ;
Mannervik, B .
BIOCHEMICAL JOURNAL, 1997, 324 :25-28
[3]   Direct genetic evidence for involvement of tau in progressive supranuclear palsy [J].
Bennett, P ;
Bonifati, V ;
Bonuccelli, U ;
Colosimo, C ;
De Mari, M ;
Fabbrini, G ;
Marconi, R ;
Meco, G ;
Nicholl, DJ ;
Stocchi, F ;
Vanacore, N ;
Vieregge, P ;
Williams, AC .
NEUROLOGY, 1998, 51 (04) :982-985
[4]   FAMILIAL PARKINSONISM WITH DEPRESSION - A CLINICOPATHOLOGICAL STUDY [J].
BHATIA, KP ;
DANIEL, SE ;
MARSDEN, CD .
ANNALS OF NEUROLOGY, 1993, 34 (06) :842-847
[5]  
BONIFATI V, 1996, MOV DISORD S1, V11, P86
[6]  
Brice A, 1998, NEUROLOGY, V50, pA117
[7]  
CALNE DB, 1994, NEUROLOGY, V44, P5
[8]   THE NACP/SYNUCLEIN GENE - CHROMOSOMAL ASSIGNMENT AND SCREENING FOR ALTERATIONS IN ALZHEIMER-DISEASE [J].
CAMPION, D ;
MARTIN, C ;
HEILIG, R ;
CHARBONNIER, F ;
MOREAU, V ;
FLAMAN, JM ;
PETIT, JL ;
HANNEQUIN, D ;
BRICE, A ;
FREBOURG, T .
GENOMICS, 1995, 26 (02) :254-257
[9]   Failure to find the α-synuclein gene missense mutation (G209A) in 100 patients with younger onset Parkinson's disease [J].
Chan, P ;
Tanner, CM ;
Jiang, X ;
Langston, JW .
NEUROLOGY, 1998, 50 (02) :513-514
[10]   Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17 [J].
Clark, LN ;
Poorkaj, P ;
Wszolek, Z ;
Geschwind, DH ;
Nasreddine, ZS ;
Miller, B ;
Li, D ;
Payami, H ;
Awert, F ;
Markopoulou, K ;
Andreadis, A ;
D'Souza, I ;
Lee, VMY ;
Reed, L ;
Trojanowski, JQ ;
Zhukareva, V ;
Bird, T ;
Schellenberg, G ;
Wilhelmsen, KC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (22) :13103-13107